Budesonide-loaded solid lipid nanoparticles for pulmonary delivery: preparation, optimization, and aerodynamic behavior

References

• Abbasalipurkabir R, Salehzadeh A, Abdullah R. 2011. Delivering tamoxifen within solid lipid nanoparticles. Pharm Technol. 35:74–79.
   Google Scholar
• Amani A, Mohammadyani D. 2011. Artificial neural networks: applications in nanotechnology. In: Hui C-L, Eds. Artificial Neural Networks – Application. Rijeka: INTECH.
   Google Scholar
• Amani A, Chrystyn H, Clark BJ, Abdelrahim ME, York P. 2009. Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers. J Pharm Pharmacol. 61:1625–1630.
   PubMed Web of Science ®Google Scholar
• Amani A, York P, Chrystyn H, Clark BJ. 2010. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech. 11:1147–1151.
   PubMed Web of Science ®Google Scholar
• Amini MA, Faramarzi MA, Gilani K, Moazeni E, Esmaeilzadeh-Gharehdaghi E, Amani A. 2014. Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles. J Microencapsul. 31:422–429.
   PubMed Web of Science ®Google Scholar
• Bai S, Thomas C, Ahsan F. 2007. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. J Pharm Sci. 96:2090–2106.
   PubMed Web of Science ®Google Scholar
• Bartos, C, Szabo-Revesz P, Ambrus R. 2014. Optimization of technological parameters by acoustic cavitation to achieve particle size reduction. Optimization. 62:1–34.
   Google Scholar
• Berne BJ, Pecora R. 2000. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. New York: Courier Dover Publications.
   Google Scholar
• Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S. 2007. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev. 59:444–453.
   PubMed Web of Science ®Google Scholar
• Cheow WS, Li S, Hadinoto K. 2010. Spray drying formulation of hollow spherical aggregates of silica nanoparticles by experimental design. Chem Eng Res Design. 88:673–685.
   Web of Science ®Google Scholar
• Czitrom V. 1999. One-factor-at-a-time versus designed experiments. Am Stat. 53:126–131.
   Web of Science ®Google Scholar
• Emami HM, Hamishehkar H, Varshosaz JJ. 2014. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res Pharm Sci. 10:17–33.
   Web of Science ®Google Scholar
• Fathinia M, Khataee AR, Zarei M, Aber S. 2010. Comparative photocatalytic degradation of two dyes on immobilized TiO2 nanoparticles: Effect of dye molecular structure and response surface approach. J Mol Catal A Chem. 333:73–84.
   Web of Science ®Google Scholar
• Fox RJ, Elgart D, Davis SC. 2009. Bayesian credible intervals for response surface optima. J Stat Plan Inference. 139:2498–2501.
   Web of Science ®Google Scholar
• Gershenson C. 2003. Artificial neural networks for beginners. UK: arXiv preprint cs/0308031.
   Google Scholar
• Höhne GW, Hemminger WF, Flammersheim HJ. 2003. Differential scanning calorimetry. Berlin: Springer.
   Google Scholar
• Hu L, Jia Y. 2010. Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery. Pharmazie Int J Pharm Sci. 65:585–587.
   Google Scholar
• Kasabov NK. 1996. Foundations of Neural Networks, Fuzzy Systems, and Knowledge Engineering. Rio de Janeiro: Marcelo Alencar.
   Google Scholar
• Kätzel U, Vorbau M, Stintz M, Gottschalk-Gaudig T, Barthel H. 2008. Dynamic light scattering for the characterization of polydisperse fractal systems: II. Relation between structure and DLS results. Part Part Syst Charact. 25:19–30.
   Web of Science ®Google Scholar
• Kaur G, Narang RK, Rath G, Goyal AK. 2012. Advances in pulmonary delivery of nanoparticles. Artif Cells Blood Substit Immobil Biotechnol. 40:75–96.
   PubMed Web of Science ®Google Scholar
• Kukowska-Latallo JF, Raczka E, Quintana A, Chen C, Rymaszewski M, Baker JR Jr. 2000. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther. 11:1385–1395.
   PubMed Web of Science ®Google Scholar
• Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, Cao F, Zhai G. 2009. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 372:191–198.
   PubMed Web of Science ®Google Scholar
• Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine. 4:299–319.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165–196.
   PubMed Web of Science ®Google Scholar
• Mezzena M, Scalia S, Young PM, Traini D. 2009. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J. 11:771–778.
   PubMed Web of Science ®Google Scholar
• Naikwade SR, Bajaj AN, Gurav P, Gatne MM, Singh Soni P.2009. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study. AAPS PharmSciTech. 10:993–1012.
   PubMed Web of Science ®Google Scholar
• Nic M, Jirat J, Kosata B, Jenkins A. 1997. Definition of electro kinetic potential in IUPAC. In: McNaught AD, Wilkinson A, Eds. Compendium of Chemical Terminology (the “Gold Book”). Oxford: Blackwell Scientific Publications.
   Google Scholar
• Patlolla RR, Chougule M, Patel AR, Jackson T, Tata PN, Singh M. 2010. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release. 144:233–241.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R. 2007. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules. 8:3054–3060.
   PubMed Web of Science ®Google Scholar
• Schick C. 2008. Differential Scanning Calorimeter (DSC) with Temperature Controlled Furnace. US Patent 7,448,796.
   Google Scholar
• Sun Y, Peng Y, Chen Y, Shukla AJ. 2003. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev. 55:1201–1215.
   PubMed Web of Science ®Google Scholar
• Sunitha R, Sireesha DS, Aparna M. 2011. Novel self-emulsifying drug delivery system-an approach to enhance bioavailability of poorly water soluble drugs. Int J Res Pharm Chem. 1:828–838.
   Google Scholar
• Suslick KS, Price GJ. 1999. Applications of ultrasound to materials chemistry. Annu Rev Mater Sci. 29:295–326.
   Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. 2014. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 86:7–22.
   PubMed Web of Science ®Google Scholar
• Zhang P, Tu Y, Wang S, Wang Y, Xie Y, Li M, Jin Y. 2011. Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery. J Chin Pharm Sci. 20:390–396.
   Google Scholar
• Zhang Y, Zhang J. 2014. Preparation of budesonide nanosuspensions for pulmonary delivery: characterization, in vitro release and in vivo lung distribution studies. Artif CellsNanomed Biotechnol. [Epub ahead of print]. DOI: 10.3109/21691401.2014.944645.
   Google Scholar